We collected serial PB samples from patients with advanced NSCLC undergoing treatment with chemo-immunotherapy, analyzed levels of the CX3CR1+ subset in CD8+ T cells, and evaluated its predictive and prognostic values of the CX3CR1 score. The gene discussed is CD8A; the disease is non-small cell lung carcinoma.